Maravai LifeSciences Inc...

NASDAQ: MRVI · Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT

Maravai LifeSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
215.85M 241.86M 259.19M 276.92M 278.58M 274.1M 288.94M 419.52M 543.91M 717.73M 883M 906.73M 920.28M 895.32M 799.24M 669.15M 552.2M 381.33M
Cost of Revenue
153.02M 151.67M 157.75M 156.01M 155.87M 160.87M 149.34M 166.89M 168.38M 162.6M 168.96M 154.84M 148.71M 148.73M 139.07M 123.32M 111.04M 94.72M
Gross Profit
62.83M 90.19M 101.44M 120.91M 122.72M 113.23M 139.6M 252.63M 375.54M 555.13M 714.04M 751.89M 771.57M 746.59M 660.17M 545.83M 441.16M 286.61M
Operating Income
-322.68M -265.92M -235.62M -197.27M -43.58M -45.68M -28.98M 80.05M 212.37M 404.69M 574.22M 619.51M 659.48M 633.02M 558.1M 434.81M 323.65M 177.53M
Interest Income
19.36M 23.42M 27.4M 28.83M 29.19M 28.89M 27.73M 22.61M 15.17M 8.38M 2.34M n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-348.96M -291.76M -261.48M 441.21M 596.29M 599.85M 617.74M 57.43M 191.75M 380.11M 551.47M 600.28M 638.17M 608.91M 531.63M 401.78M 288.8M 143.74M
Net Income
-194.72M -162.71M -144.85M -224.66M -132.08M -131.04M -120.31M 73.08M 179.19M 342.45M 490.66M 459.06M 413.69M 306.04M 182.43M 151.81M 136.48M 87.61M
Selling & General & Admin
158.47M 160.45M 152.08M 144.47M 144.24M 139.06M 146.54M 150.12M 142.05M 134.73M 129.26M 117.64M 112.03M 108.06M 98.09M 114.13M 109.45M 101.36M
Research & Development
18.68M 19.08M 19.22M 19.25M 19.26M 18.17M 17.28M 17.7M 18.74M 18.82M 18.37M 22.54M 19.1M 16.76M 15.23M 8.14M 8.06M 7.72M
Other Expenses
208.37M 176.58M 164.15M 152.86M 1.19M 2.38M 2.55M 2.55M 164K 164K 3K 204K 286K 283K 279K 78K 32K 55K
Operating Expenses
385.51M 356.11M 335.45M 316.58M 164.69M 159.62M 166.2M 170.2M 160.78M 153.55M 147.63M 140.18M 131.13M 124.82M 113.32M 122.27M 117.51M 109.08M
Interest Expense
38.49M 43.61M 47.7M 51.84M 49.84M 44.92M 45.89M 40.67M 32.17M 29.58M 20.41M 17.26M 21.8M 25.02M 30.26M 32.04M 31.45M 31.26M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
538.54M 507.77M 494.8M 474.19M 322.16M 322.09M 315.55M 337.08M 329.16M 316.15M 316.58M 295.02M 279.85M 273.55M 252.39M 245.59M 228.54M 203.8M
Income Tax Expense
-3.82M -1.97M -1.86M 764.32M 758.54M 759.56M 756.11M -1.61M 17.96M 37.65M 60.81M 69.94M 74.67M 67.79M 61.52M 44.31M 25.11M 12.95M
Shares Outstanding (Basic)
144.24M 143.43M 141.81M 141.56M 135.84M 132.33M 132.14M 131.93M 131.86M 131.74M 131.63M 131.54M 131.5M 131.5M 131.46M 118.43M 112.2M 96.65M
Shares Outstanding (Diluted)
144.24M 143.43M 139.73M 141.56M 135.84M 132.33M 132.14M 131.93M 131.86M 131.74M 131.65M 131.65M 121.97M 121.97M 121.97M 121.97M 112.28M 96.67M
EPS (Basic)
-1.36 -1.15 -1.03 -1.65 -1 -0.99 -0.91 0.55 1.36 2.60 3.73 3.49 3.19 2.44 1.56 1.40 1.38 0.94
EPS (Diluted)
-1.36 -1.15 -1.03 -1.65 -1 -0.99 -0.91 0.55 1.36 2.69 3.90 3.66 3.34 2.50 1.54 1.34 1.34 0.90
EBITDA
-284.12M -208.29M -156.92M 548.36M 700.5M 696.4M 712.41M 141.99M 264.63M 447.5M 608.05M 651.01M 691.48M 664.72M 591.19M 471.25M 356.4M 209.43M
EBIT
-310.47M -248.15M -213.78M 493.04M 646.13M 644.77M 658.85M 93.32M 219.15M 404.91M 571.89M 614.09M 657.38M 632.2M 561.02M 436.42M 321.94M 175.84M
Depreciation & Amortization
43.48M 58.02M 56.87M 55.32M 54.38M 51.63M 48.78M 44M 40.81M 37.92M 36.27M 33.47M 30.64M 29.07M 26.71M 27.23M 26.83M 25.96M